Abstract
Background: Dexlansoprazole is a proton pump inhibitor (PPI) approved for use in dual delayed-release capsule and orally disintegrating tablet (ODT) f......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
